Basic Information
RNALocate ID: RLID:01002790
RNA Symbol: hsa-miR-1275
Localization: Nucleolus
RNA Information
RNA Name: hsa-miR-1275
RNA ID: miRBase:MIMAT0005929
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23940654
Tissue/Cell Line: HeLa cells
Method: qRT-PCR

Detection of mature miRNAs in the HeLa nucleolus. The abundance ratios of the detected miRNAs in nucleolus vs. whole cells are plotted against their abundance in the nucleolus. The box encompasses the miRNAs with high nucleolar abundance (Ct smaller than 30) and nucleolar/cell ratio that exceeds 0.3.

Originally published in PLoS One. Li ZF, et al, 2013. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)

Description: Even under such stringent criteria, 11 miRNAs can be identified as miRNAs that are detectable in the nucleolus with very high levels of confidence (Figure 1D, Table S2). Since the detected nucleolar contents of many of these RNAs are very high, we termed these 11 miRNAs as “nucleolar miRNAs”.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002786 Mitochondrion HeLa cells 27396686
RLID:01002787 Mitochondrion HeLa cells 27563705
RLID:01002788 Mitochondrion Cell line (HeLa) 21695135
RLID:01002789 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002837 Cytosol Cell line (HeLa) 21695135
RLID:01002838 Mitochondrion Cell line (HeLa) 21695135
RLID:11004346 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11004347 Exosome B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells 25242326
RLID:11004348 Microvesicle Seminal plasma 23539611
RLID-D:11000791 Microvesicle Colon cancer cell line (LIM1863)|Mesenchymal stem cells
RLID-D:11001721 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-1275 Oral squamous cell carcinoma MNDR-E-MI-08791
MNDR hsa-miR-1275 Estrogen-receptor positive breast cancer MNDR-E-MI-08792
MNDR hsa-miR-1275 Estrogen-receptor negative breast cancer MNDR-E-MI-08793
MNDR hsa-miR-1275 Progesterone-receptor positive breast cancer MNDR-E-MI-08794
MNDR hsa-miR-1275 Progesterone-receptor negative breast cancer MNDR-E-MI-08795
MNDR hsa-miR-1275 Her2-receptor positive breast cancer MNDR-E-MI-08796
MNDR hsa-miR-1275 Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-08797
MNDR hsa-mir-1275 Colorectal carcinoma MNDR-E-MI-08798
MNDR hsa-miR-1275 B cell acute lymphoblastic leukemia MNDR-E-MI-08799
MNDR hsa-miR-1275 Prostate cancer MNDR-E-MI-08800
MNDR hsa-miR-1275 Alzheimer disease MNDR-E-MI-08801
MNDR hsa-miR-1275 Intracranial aneurysm MNDR-E-MI-08802
MNDR hsa-miR-1275 Polycystic ovary syndrome MNDR-E-MI-08803
MNDR hsa-miR-1275 Head and neck cancer MNDR-E-MI-08804
MNDR hsa-miR-1275 Lung cancer MNDR-E-MI-08805
MNDR hsa-miR-1275 Parkinson disease MNDR-E-MI-08806
MNDR hsa-miR-1275 Breast cancer MNDR-E-MI-08807
MNDR hsa-mir-1275 Squamous carcinoma MNDR-E-MI-08808
MNDR hsa-miR-1275 Pancreatic cancer MNDR-E-MI-08809
MNDR hsa-miR-1275 Nephroblastoma MNDR-E-MI-08810
MNDR hsa-miR-1275 Multiple sclerosis MNDR-E-MI-08811
MNDR hsa-miR-1275 Multiple sclerosis relapsing-remitting MNDR-E-MI-08812
MNDR hsa-miR-1275 Ovarian cancer MNDR-E-MI-08813
MNDR hsa-miR-1275 Glioma MNDR-E-MI-08814
MNDR hsa-miR-1275 Amyotrophic lateral sclerosis MNDR-E-MI-08815
MNDR hsa-miR-1275 Liver cancer MNDR-E-MI-08816
MNDR hsa-mir-1275 Non-small cell lung cancer MNDR-E-MI-08817
MNDR hsa-miR-1275 Lung adenocarcinoma MNDR-E-MI-08818
MNDR hsa-miR-1275 Thyroid carcinoma MNDR-E-MI-08819
MNDR hsa-miR-1275 Pancreatic adenocarcinoma MNDR-E-MI-08820
MNDR hsa-miR-1275 Intrahepatic cholangiocarcinoma MNDR-E-MI-08821
MNDR hsa-miR-1275 Cholangiocarcinoma MNDR-E-MI-08822
MNDR hsa-miR-1275 Adenoma MNDR-E-MI-08823
MNDR hsa-miR-1275 Progressive supranuclear palsy MNDR-E-MI-08824
MNDR hsa-mir-1275 Carcinoma hepatocellular MNDR-E-MI-08825
MNDR hsa-miR-1275 Hepatocellular carcinoma MNDR-E-MI-08826
MNDR hsa-miR-1275 Hodgkin lymphoma MNDR-E-MI-08827
MNDR hsa-miR-1275 Acute myelocytic leukemia MNDR-E-MI-08828
MNDR hsa-mir-1275 Colorectal cancer MNDR-E-MI-08829
MNDR hsa-mir-1275 Nasopharyngeal carcinoma MNDR-E-MI-08830
MNDR hsa-miR-1275 Nasopharynx carcinoma MNDR-E-MI-08831
MNDR hsa-miR-1275 Nasopharyngeal cancer MNDR-E-MI-08832
MNDR hsa-miR-1275 Pseudorabies MNDR-E-MI-08833
MNDR hsa-miR-1275 Subarachnoid hemorrhage traumatic MNDR-E-MI-08834
MNDR hsa-miR-1275 Stroke lacunar MNDR-E-MI-08835
MNDR hsa-miR-1275 Breast cancer her3+ negative MNDR-E-MI-08836
MNDR hsa-mir-1275 Multiple sclerosis susceptibility MNDR-E-MI-08837
MNDR hsa-mir-1275 Stroke susceptibility MNDR-E-MI-08838
MNDR hsa-miR-1275 Tubulovillous adenoma MNDR-E-MI-08839
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AK3 Homo sapiens RR00064570
TOP